Targeting Interleukin 13 for the Treatment of Atopic Dermatitis
Atopic dermatitis (AD) is a common chronic inflammatory skin condition that has a significant impact on a patient’s quality of life and requires ongoing management. Conventional topical and systemic therapies do not target specific components of AD pathogenesis and, therefore, have limited efficacy...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2023-02-01
|
| Serija: | Pharmaceutics |
| Teme: | |
| Online pristup: | https://www.mdpi.com/1999-4923/15/2/568 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|